CPCristina Pagni

Cristina Pagni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cristina Pagni has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Social Cognition and Oxytocin in Huntington’s Disease: New Insights

    by Elisa Unti, Sonia Mazzucchi, Daniela Frosini, Cristina Pagni, Gloria Tognoni, Lionella Palego, Laura Betti, Fabiana Miraglia, Gino Giannaccini, Roberto Ceravolo

    This study is aimed at relating social cognition in Huntington’s Disease (HD) to plasma levels of the social hormone oxytocin (OT). Indeed, HD patients commonly display reduced social skills and OT is involved in bonding behavior and improved recognition of facial emotions. Twelve mild-symptomatic HD patients (stage II Shoulson & Fahn) and 11 gender/age matched controls (healthy controls, HC), without concurrent psychiatric disorders, were investigated at baseline (T0) for OT plasma levels and social cognition through an extensive battery of neuropsychological tests. Social cognition was also re-examined after two years (T1) in 8 of the 12 patients. Results showed a trend for reduced T0-OT levels in HD vs. HC, mean ± stardard deviation: 6.5 ± 2.4 vs. 9.9 ± 7.2 pg/mL, without reaching statistical significance. At T0, patients showed significantly lower performances than controls at the “Faux-Pas” and “Strange Stories” tests (p < 0.05; p < 0.01); a reduced perception of visual emotions (p < 0.01) and verbal stimuli (p < 0.01) was also reported, involving anger, fear, and sadness (p < 0.05; p < 0.01). Additionally, in the HD population, OT concentrations positively correlated with T1-performances at Neutral\Faux-Pas test (p < 0.05), whereas the cognitive Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) scores positively correlated with psychosocial perception at the “Strange Stories” and Karolinska Directed Emotional Faces (KDEF) tests (p < 0.05). This study, despite its limitations, supports correlations between OT and HD social cognition, suggesting a possible therapeutic use of this hormone. More subjects and additional body tissues/fluids, such as cerebrospinal fluid, should be investigated to confirm this hypothesis.


  • F5 Social cognition in huntington’s disease: evidence from a prospective study

    by Elisa Unti, Sonia Mazzucchi, Giovanni Palermo, Lorenzo Kiferle, Cristina Pagni, Gloria Tognoni, Ubaldo Bonuccelli, Roberto Ceravolo

    Background Impaired social behaviour, partly related to altered perception of emotions, is commonly reported in Huntington’s disease (HD). Aims To evaluate social cognition in symptomatic HD patients and its possible predictors. Methods 12 HD patients (stage II S&F, CAG 40.5 ± 2.5) and 9 healthy controls, matched for age and educational level, performed neuropsychological (Montreal Cognitive assessment- MoCa; Mini Mental State Assessment- MMSE; Frontal Assessment Battery- FAB) and social cognition batteries (Faux Pas test, Bush vignettes test, emotion recognition from both faces expression and verbal stimuli, Strange stories test). After 2 years 8 HD patients were re-evaluated through the same tests. Results HD patients, comparing to controls, showed lower performances in social cognition, particularly in Faux pas test and Strange Stories, and in recognising negative emotions from face expression (KDEF scale) and verbal emotions (p < 0.05, p < 0.01), as well as cognitive impairment expressed by MoCa, MMSE and FAB (p < 0.01). MoCa and MMSE showed positive correlation with social cognitive tests. At the follow up there were no significative differences in motor and cognitive scales (baseline: MoCa 18.6 ± 4.7, MMSE 26.5 ± 2.2, UHDRS 35.2 ± 8.2); (Follow-up: MoCa 19.8 ± 5.6, MMSE 25.5 ± 3.4, UHDRS 36 ± 11.2). Statistical analysis revealed a negative correlation between CAG and Bush vignettes Score (p < 0.05). Moreover, patients with higher MoCa scores at the baseline showed better performances in KDEF total score (p < 0.05), in particular disgust (p < 0.05), and at the strange stories test (p < 0.01); whereas MMSE showed positive correlation only with strange stories test (p < 0.05). Conclusions The present study, albeit limited by small sample size, confirms an impairment of social cognition in HD; in addition it suggests CAG expansion and cognitive performances (MoCa and MMSE scores) as possible predictors of social cognition impairment in the course of the disease.

  • Open Access

    The Epidemiology and Clinical Manifestations of Dysexecutive Syndrome in Parkinson’s Disease

    by Roberto Ceravolo, Cristina Pagni, Gloria Tognoni, Ubaldo Bonuccelli

    This mini-review summarizes the evidence of the cognitive and behavioral features of dysexecutive syndrome in Parkinson’s disease (PD). Deficits in response inhibition, set-shifting, mental flexibility, and strategy have been frequently described from the earliest stages of PD, although there are inconsistencies in study findings due to the complexity of the executive function (EF) construct and methodological limitations. Behavioral disorders of PD, e.g., apathy, distractibility, perseverative behavior, and impulse-control disorders, may be viewed as the other side of dysexecutive syndrome. Despite the interrelationship between the cognitive and behavioral domains, some reports reveal that the two syndromes may be dissociated, suggesting that both aspects must be clinically assessed. EFs are widely associated with the prefrontal areas, although dysexecutive syndrome may be observed in patients with damage to other brain regions. EFs drive numerous abilities essential to daily life, such as prospective remembering and language comprehension, which may be impaired in PD subjects. Considering the impact of dysexecutive syndrome on independence and quality of life, early detection of executive impairment is crucial in the management of PD.